These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 5485600)

  • 1. Drug sensitivity of exo-erythrocytic stages in pyrimethamine-resistant Plasmodium berghei.
    Diggens SM; Gregory KG
    Trans R Soc Trop Med Hyg; 1970; 64(4):468-9. PubMed ID: 5485600
    [No Abstract]   [Full Text] [Related]  

  • 2. Sustained-release implants in the chemotherapy of experimental rodent malaria I. A comparison of the effects of some antimalarials in polydimethylsiloxane matrices.
    Howells RE; Judge BM
    Ann Trop Med Parasitol; 1981 Oct; 75(5):495-510. PubMed ID: 7032430
    [No Abstract]   [Full Text] [Related]  

  • 3. A comparison of the pyrimethamine and cycloguanil sensitivities of the pre-erythrocytic and erythrocytic stages of drug-sensitive and -resistant strains of Plasmodium yoelii.
    Howells RE; Gilles HM; Bent NS
    Ann Trop Med Parasitol; 1985 Jun; 79(3):247-51. PubMed ID: 4026437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gametocytocidal and sporontocidal effects of primaquine and of sulfadiazine with pyrimethamine in a chloroquine-resistant strain of Plasmodium falciparum.
    Rieckmann KH; McNamara JV; Frischer H; Stockert TA; Carson PE; Powell RD
    Bull World Health Organ; 1968; 38(4):625-32. PubMed ID: 4876731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Chemotherapeutic activity of standard antimalarials in a simplified test for Plasmodium vinckey infection in the NMPI mouse].
    Fink E; Kretschmar W
    Z Tropenmed Parasitol; 1970 Jun; 21(2):167-81. PubMed ID: 4987848
    [No Abstract]   [Full Text] [Related]  

  • 6. Sustained-release implants in the chemotherapy of experimental rodent malaria II. The effects of sulphadiazine, pyrimethamine and cycloguanil in biodegradable polymer matrices.
    Judge BM; Howells RE; Graham NB; McNeill ME
    Ann Trop Med Parasitol; 1981 Oct; 75(5):511-9. PubMed ID: 7032431
    [No Abstract]   [Full Text] [Related]  

  • 7. Drug resistance in Plasmodium berghei Vincke and Lips, 1948. II. Triazine resistance.
    Peters W
    Exp Parasitol; 1965 Aug; 17(1):90-6. PubMed ID: 5843290
    [No Abstract]   [Full Text] [Related]  

  • 8. Drug resistance in Plasmodium berghei Vincke and Lips, 1948. I. Chloroquine resistance.
    Peters W
    Exp Parasitol; 1965 Aug; 17(1):80-9. PubMed ID: 5843289
    [No Abstract]   [Full Text] [Related]  

  • 9. The chemotherapy of rodent malaria. IX. Causal prophylaxis. I. A method for demonstrating drug action on exo-erythrocytic stages.
    Gregory KG; Peters W
    Ann Trop Med Parasitol; 1970 Mar; 64(1):15-24. PubMed ID: 5485706
    [No Abstract]   [Full Text] [Related]  

  • 10. Single step production of pyrimethamine-resistant P. berghei.
    Diggens SM
    Trans R Soc Trop Med Hyg; 1970; 64(1):9. PubMed ID: 5442095
    [No Abstract]   [Full Text] [Related]  

  • 11. Characteristics and cross-resistance patterns of chloroquine-resistant Plasmodium berghei infections in mice.
    Schneider MD
    Exp Parasitol; 1968 Aug; 23(1):22-50. PubMed ID: 5691706
    [No Abstract]   [Full Text] [Related]  

  • 12. Quantitative aspects of pyrimethamine-sulfonamide synergism.
    Schmidt LH; Harrison J; Rossan RN; Vaughan D; Crosby R
    Am J Trop Med Hyg; 1977 Sep; 26(5 Pt 1):837-49. PubMed ID: 410317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug-resistant malaria--changing patterns mean difficult decisions.
    Spencer HC
    Trans R Soc Trop Med Hyg; 1985; 79(6):748-58. PubMed ID: 3914115
    [No Abstract]   [Full Text] [Related]  

  • 14. Potentiating action of sulfalene-pyrimethamine mixtures against drug-resistant strains of Plasmodium berghei.
    Peters W
    Chemotherapy; 1971; 16(6):389-98. PubMed ID: 5145011
    [No Abstract]   [Full Text] [Related]  

  • 15. The chemotherapy of rodent malaria. XII. Substituted tetrahydrofurans, a new chemical family of antimalarials. The action of 2-(p-chlorophenyl)-2-(4-piperidyl)-tetrahydrofuran against Plasmodium berghei and Plasmodium chabaudi.
    Peters W
    Ann Trop Med Parasitol; 1970 Jun; 64(2):189-202. PubMed ID: 5497391
    [No Abstract]   [Full Text] [Related]  

  • 16. Cytochrome P450 2D-mediated metabolism is not necessary for tafenoquine and primaquine to eradicate the erythrocytic stages of Plasmodium berghei.
    Milner EE; Berman J; Caridha D; Dickson SP; Hickman M; Lee PJ; Marcsisin SR; Read LT; Roncal N; Vesely BA; Xie LH; Zhang J; Zhang P; Li Q
    Malar J; 2016 Dec; 15(1):588. PubMed ID: 27923405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preliminary studies on the anti-malarial activity of SDDS (2-sulfamoyl-4, 4'-diaminodiphenylsulfone) against Plasmodium berghei and Plasmodium gallinaceum.
    Ishii A; Sasa M; Chinzei H; Oshima S; Tanaka H
    Jpn J Exp Med; 1967 Aug; 37(4):301-21. PubMed ID: 5301401
    [No Abstract]   [Full Text] [Related]  

  • 18. Antimalarial drug resistance: an increasing problem.
    Peters W
    Br Med Bull; 1982 May; 38(2):187-92. PubMed ID: 7052200
    [No Abstract]   [Full Text] [Related]  

  • 19. [Causal preventive activity of standard antimalarials in rodent malaria (Plasmodium berghei yoelii)].
    Fink E
    Z Tropenmed Parasitol; 1972 Mar; 23(1):35-48. PubMed ID: 5050530
    [No Abstract]   [Full Text] [Related]  

  • 20. Drug responses of mepacrine- and primaquine-resistant strains of Plasmodium berghei Vincke and Lips, 1948.
    Peters W
    Ann Trop Med Parasitol; 1966 Mar; 60(1):25-30. PubMed ID: 5960105
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.